γ-Secretase cleavage of the Alzheimer risk factor TREM2 is determined by its intrinsic structural dynamics.
Andrea SteinerKai SchlepckowBettina BrunnerHarald SteinerChristian HaassFranz HagnPublished in: The EMBO journal (2020)
Sequence variants of the microglial expressed TREM2 (triggering receptor expressed on myeloid cells 2) are a major risk factor for late onset Alzheimer's disease. TREM2 requires a stable interaction with DAP12 in the membrane to initiate signaling, which is terminated by TREM2 ectodomain shedding and subsequent intramembrane cleavage by γ-secretase. To understand the structural basis for the specificity of the intramembrane cleavage event, we determined the solution structure of the TREM2 transmembrane helix (TMH). Caused by the presence of a charged amino acid in the membrane region, the TREM2-TMH adopts a kinked structure with increased flexibility. Charge removal leads to TMH stabilization and reduced dynamics, similar to its structure in complex with DAP12. Strikingly, these dynamical features match with the site of the initial γ-secretase cleavage event. These data suggest an unprecedented cleavage mechanism by γ-secretase where flexible TMH regions act as key determinants of substrate cleavage specificity.
Keyphrases
- dna binding
- structural basis
- late onset
- amino acid
- transcription factor
- risk factors
- early onset
- cognitive decline
- induced apoptosis
- bone marrow
- inflammatory response
- dendritic cells
- copy number
- cell death
- cell cycle arrest
- signaling pathway
- oxidative stress
- gene expression
- spinal cord injury
- immune response
- cell proliferation
- big data
- endoplasmic reticulum stress